1. Home
  2. LITE vs EXAS Comparison

LITE vs EXAS Comparison

Compare LITE & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lumentum Holdings Inc.

LITE

Lumentum Holdings Inc.

N/A

Current Price

$682.62

Market Cap

24.1B

ML Signal

N/A

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

N/A

Current Price

$103.47

Market Cap

19.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LITE
EXAS
Founded
2015
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.1B
19.7B
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
LITE
EXAS
Price
$682.62
$103.47
Analyst Decision
Buy
Hold
Analyst Count
14
17
Target Price
$574.31
$86.62
AVG Volume (30 Days)
4.5M
1.9M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
104.56
80.32
EPS
0.99
N/A
Revenue
$1,247,700,000.00
$4,144,000.00
Revenue This Year
$78.72
$15.37
Revenue Next Year
$56.97
$12.41
P/E Ratio
$560.70
N/A
Revenue Growth
24.57
N/A
52 Week Low
$45.66
$38.88
52 Week High
$780.00
$103.87

Technical Indicators

Market Signals
Indicator
LITE
EXAS
Relative Strength Index (RSI) 58.55 58.57
Support Level $135.23 $102.95
Resistance Level $780.00 $103.77
Average True Range (ATR) 53.01 0.31
MACD -13.39 -0.07
Stochastic Oscillator 58.97 48.13

Price Performance

Historical Comparison
LITE
EXAS

About LITE Lumentum Holdings Inc.

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: